z-logo
open-access-imgOpen Access
Nosocomial outbreak by Proteus mirabilis producing extended-spectrum β-lactamase VEB-1 in a Korean university hospital
Author(s) -
Jayoung Kim,
Yeon-Joon Park,
Sang-Il Kim,
Moon Won Kang,
Seungok Lee,
Kyo-Young Lee
Publication year - 2004
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkh486
Subject(s) - cefotaxime , ceftazidime , proteus mirabilis , microbiology and biotechnology , imipenem , aztreonam , cefoxitin , piperacillin , cefepime , cefuroxime , cephalosporin , cefpodoxime , tazobactam , biology , antibiotics , antibiotic resistance , pseudomonas aeruginosa , bacteria , genetics , staphylococcus aureus
To examine the molecular mechanisms involved in the beta-lactam resistance of multidrug-resistant Proteus mirabilis isolates that showed an unusual synergy between imipenem and ceftazidime in a Korean hospital.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom